A Comparison of the Gingival Health of Children with Down Syndrome to Healthy Children Residing in an Institution by Morinushi, Takanobu et al.
C O M P A R I S O N  O F  G I N G I V A L  H E A L T H  
,.‘ . 
:The purpose of this study was to 
; oompars the onset and severity of 
I gingivitis in children with Down 
rprdmme, when compared to a healthy 
Eontrol group of children. The subjects 
included 41 children with Down 
qndmme ages two to 14 years (mean 
age: 7.8 years) and 1 12 age-matched 
heelthy controls. We assessed the 
dngival health of all subjects using the 
Qingival inflammation (M-PMA) index 
and periodontal probing depth (PO). 
Children were divided into three age 
categories: <5 years (AD, 5 to <10 years 
(All), and 10 to < 17 years (Alll). 
Supragingival plaque was measured 
using the Oral Hygiene Index (OHI) 
and the subjects were screened with 
the BANA test (Perioscan-Oral-6). 
Measurement of the M-PMA index in the 
healthy children showed an age-related 
increase (F=10.369, p<O.OOl). and the 
M-PMA index at the younger age group 
<S year (AD was significantly lower than 
that for the other two age groups All or 
All (p<0.005, p<O.OOl). In contrast, the 
M-PMA index values at Al and All1 in the 
subjects with Down syndrome were 
Significantly higher than those for 
healthy children @<0.001, p<O.001). 
Both groups had an age-related increase 
in PD (F=3.388, p<0.05 8 F=10.806, 
p<O.oOl), and PD at All1 was 
significantly higher than that at Al in 
both groups (p<O.Ol, p<O.OOl). The 
children with Down syndrome showed 
an age-related increase in the BANA 
test score (F=3.452, p<O.O5), and the 
BANA test score at All1 was significantly 
higher than that at Al [p<O.O2). The BANA 
test score in the healthy children was 
not age-related but was significantly 
higher than that in the children with 
Down syndrome (p<0.02, p<0.05). 
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I n t r o d u c t i o n  
Down syndrome is a genetic disease resulting from trisomy of the 21st chromosome. 
The overall prevalence of Down syndrome in Japan is 5.82 per 10,000 live births.’ It 
has been reported that periodontal disease occurs, with high prevalence, in preschool 
children with Down syndrome and that its features are similar to those of severe 
juvenile periodontal disease.L It has been suggested that the early onset and severity 
of periodontal disease is related to immunological dysfunctions, including neutrotaxis, 
dysfunction of T-cells, deficient phagocytosis and increased prostaglandin E2 levels 
in gingival sulcus fluid.5 lo Cichon et all’ reported that changes in the immunological 
response due to alterations of the subgingival flora were one of the causes of 
periodontal disease in persons with Down syndrome. Periodontopathic bacteria in 
persons with Down syndrome have also been investigated.” l3  These studies have 
suggested that periodontopathogens in preschool-age children with Down syndrome 
become established in early childhood, usually with Actinobacillus 
actinomycetemcomitans in gingivitis and Povphyromonas gingivalis in periodontitis, with 
both the early onset of periodontal disease and the tendency for the disease to be 
severe. However, few studies have examined the differences in gingivitis caused by 
these two species of bacteria in children with and without Down syndr~me.’~-’~ 
Although reports have described various factors that might contribute to periodontal 
disease in children with Down syndrome, no adequate explanation for the early onset 
of gingivitis and the tendency for severe periodontal disease in these children has 
been reported. 
While several studies”J* have shown 
that periodontal treatment did not 
inhibit the progression of periodontal 
disease in subjects with Down syndrome, 
the effectiveness of frequent preventive 
care and periodontal treatment in 
these subjects has only recently been 
reported.ly,zO These reports suggest that 
an immunological problem is not a 
factor that makes prevention and care 
of periodontal disease in patients with 
Down syndrome difficult. To further 
elucidate the characteristics of 
periodontal disease in Down syndrome, 
it is important to do standard clinical 
evaluations and also examine the 
exposure to periodontopathogens in 
children with Down syndrome during 
childhood and adolescence and compare 
it with that of healthy children. This 
study evaluated the generally accepted 
reports of early onset of gingivitis 
and examined the progression of 
periodontal disease in subjects with 
Down syndrome undergoing nonspecific 
periodic preventive care, compared 
with that of healthy children residing 
in an institution. 
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Age Group Categories Down Syndrome Patients Healthy Children 
- Male ~- Female Total Average Age Male Female Total Average Age 
<5yr. AI-G 9 4 13 3.3yr 9 4 13 2.7yr. 
5 to <lOyr. AII-G 9 6 15 7.9yr 23 14 37 6.9yr. 
>= 1 Oyr. AIII-G 9 4 13 11.6yr 35 27 62 11.9yr. 
Total 27 14 41 7.6yr 37 45 112 9.2yr. 
Mater ia ls  and Methods 
Subjects 
This study was carried out in 
accordance with the Helsinki Declaration 
of 1975, as revised in 1983. Informed 
consent was obtained from the subjects, 
their parents and the persons in charge 
at the institutions. 
The group with Down syndrome 
consisted of 41 children (27 boys and 
14 girls) ages two to 14 years old (average 
age: 7.6 years), who were patients of 
the Department of Pediatric Dentistry in 
the hospital affiliated with the University 
School of Dentistry. The control group 
consisted of 112 healthy children (67 
boys and 45 girls) ages two to 14 years 
old (average age: 9.2 years) living in 
institutions for homeless or neglected 
children (Table 1). The criteria for 
inclusion were as follows: 1) no antibiotic 
treatment for at least three months before 
the sampling; 2) informed consent from 
subjects in both the group with Down 
syndrome and the control group; and 
3) establishment of a friendly relationship 
between the examiner and subjects before 
sampling. The subjects were divided into 
three age categories: 15 years (AI), 5 to 
<10 years (All) and 10 to <17 years (AIII). 
The subjects with Down syndrome 
received an oral examination and 
preventive care four times a year. The 
preventive care treatments included 
professional tooth cleaning, various 
combinations of scaling, counseling of 
the caregiver and fluoride treatment for 
caries and periodontal disease therapy. 
The healthy children received only an 
oral examination twice a year without 
fluoride treatment and did not receive 
specific instructions about prevention or 
other treatment. 
CI in ical Examinations 
One examiner performed all of the 
clinical examinations. 
Gingival condition-The degree of 
gingival inflammation was scored using 
the Modified Total PMA (M-PMA) Index 
based on the PMA Index proposed by 
Massler." The presence or absence of 
gingivitis was noted in each of the following 
three areas in the buccal or labial gingiva: 
the gingival papillae (P), the gingival 
margin (MI and the attached gingiva (A). 
Each of these areas was scored according to 
the presence or absence of inflammation 
as 1 or 0, respectively. The M-PMA index 
of each subject was defined as M-PMA 
index=(summation of PMA indices)/ 
(number of examined areas)x lOO(%) .  
Extent of supragingival plaque-The 
extent of supragingival plaque (PI) was 
evaluated by stratifying plaque in the 
subject's teeth into four grades based on 
the Oral Hygiene Index proposed by 
Greene & Vermillion.** 
Microbiological examinations- 
Subgingival plaque samples were 
analyzed for the presence of anaerobic 
periodontal pathogens, Povphyromonas 
gingivalis, Tieponema denticola and 
Bacteroides forsythus, using the BANA 
(benzoyl-DL-arginine-nap hthylamide) 
test (Perioscanm, Oral-B Laboratories 
Inc., Redwood City, CA)23 15. After the 
removal of supragingival plaque, 
subgingival plaque samples were taken 
from mesiobuccal surfaces of four first 
molars or deciduous second molars, and 
four central incisors or deciduous central 
incisors using a No. 6 dental explorer, 
and were then wiped onto BANA- 
impregnated lower strips at the bottoms 
of the BANA reagent cards. If these teeth 
were not present, plaque samples from 
adjacent teeth were used. The reaction 
was immediately activated by water 
applied to the upper strip containing fast 
black dye. The lower strip was folded 
onto the upper strip, and both strips 
were held in place with a metallic clip. 
The card was placed in an incubator at 
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Total-PMA Score 
Age Categories Down Syndrome Group Healthy children group Significance” 
Mean f SD Mean f SD 
AI-G (<Syr.) 0.312 *0.179 > 0.052 p<O.OOI 
AII-G ( 5  to <10yr.) 0.309 f0. I89 0.2 15 f 0.149 1 NS 
P<0.0001 
0.422 f0.122 > 0.244 *O. 140 p<O.OOI 
AIII-G (>=1 Oyr.) 
F=1.961 - F =10.369 p <0.0001 
*Differences between Down and control subjects were assessed by Mann-Whitney U test. 
Differences between age categories were assessed by ANOVA. 
55” for 15 minutes. Results were 
recorded as “strong, dark-blue spots” 
(score = 3 ) ,  “weak, light-blue spots” 
(score = 2) or “no color change” (score = 
1). The BANA score of each subject was 
defined as mean values of BANA scores 
of the eight examined teeth. 
Probing depth-Probing depth (PD) 
was measured to the nearest millimeter 
with a round-ended probe of 0.4mm in 
diameter at the same eight sites as those 
used those for the BANA test. 
Analysis 
All clinical index values were mean 
values, obtained by dividing the sum 
total of all individual measurements 
by the number of measurements. The 
Mann-Whitney U-test was used to assess 
mean values between the two groups. 
Distributions among the three age 
categories were assessed by ANOVA. 
Correlation was estimated by using 
Spearman’s correlation coefficient by 
ranks. A p-value <0.05 was considered 
statistically significant. 
Results 
Several significant correlations 
between clinical indices were identified 
when individuals within specific age 
categories in the control group were 
examined. For example, for children in 
the age group 5 to <10 years (AII), there 
was a significant correlation between 
M-PMA and PD (z=2.808, p<0.005), 
and significant correlations were found 
between M-PMA and PI (z=3.787, 
p<O.OOl) and between M-PMA and PD 
(z=3.004, p<O.OOl) in the control subjects. 
Relationship between Age 
and Gingivitis 
No significant change in M-PMA 
index was found in any of the age groups 
in the children with Down syndrome. 
[Table 21 By comparison, in the healthy 
children, the M-PMA index increased in 
the age group AIII compared to that at 
A1 (F=10.369, p<O.OOI), and the M-PMA 
index for children aged <5 years (AI) was 
significantly lower than that for A11 or 
AIII (p<O.OOI, p<O.OOl). When the two 
sample groups of children were compared 
for each category, M-PMA values for 
A1 and AIII, the children with Down 
syndrome had significantly higher 
readings (p<O.OOl, p<O.OOI) than those 
for the healthy children. 
Probing Depth 
The children with Down syndrome 
were found to have a significant increase 
in probing depth with increasing age 
(F=3.388, p<0.05). The probing depth 
for the AIII age group was significantly 
greater than that for A1 (p<O.OI) 
[Table 31. The healthy children also had 
an age-related increase in probing depth 
(F=10.806, p<O.OOOI). Probing depth for 
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children aged <5 years was significantly 
less than that for the other two age 
groups (p<0.003, p<O.OOOl). When 
similar age categories of children with 
Down syndrome were compared to the 
control group, no significant differences 
in probing depth were found. 
Relationshi s with Results of 
the BANA P est 
When plaque samples from the 
children with Down syndrome were 
examined, a significant age-related 
increase in BANA score was found 
(Fz3.452, p<0.05). Similarly, BANA 
scores for the oldest children were 
significantly higher than for the youngest 
( ~ ~ 0 . 0 2 ) .  The BANA scores of the 
healthy children, however, showed no 
significant relationship with age. When 
the BANA scores of both sample groups 
were compared for each age category, the 
children in the control group had 
significantly higher scores for age group 
A1 and A11 than did the children with 
Down syndrome (p<0.02, p<0.05) 
(Table 4). 
Plaque Index 
No significant age-related changes 
were noted in the plaque index, either in 
the group of children with Down 
syndrome or the control group. 
Discuss ion 
It has been reported that children 
with Down syndrome develop 
periodontal disease early in childhood at 
a comparatively high rate, with clinical 
findings similar to those of severe 
juvenile periodontal These 
findings have been attributed to 
immunological deficits6 lo 26 The 
microbiota associated with periodontal 
disease in children with Down syndrome 
have also been reported,12 l 3  suggesting that 
periodontopathogens in preschool-age 
children with Down syndrome become 
established in early childhood. It has 
been reported that Actinobacillus 
actinornyceterncomitans in gingivitis and 
Porphyrornonas gingivalis in periodontitis 
are associated with early onset and a 
tendency for the disease to be  severe."^" 
Because of these factors, the occurrence 
of periodontal disease in subjects with 
Down syndrome might be unavoidable, 
and it has been thought that the progress 
of the disease cannot be prevented. 
However, some recent reportsY," z8 have 
suggested the effectiveness of preventive 
care in suppressing the onset and 
progression of periodontal disease in this 
population. Shapira et all7 reported that 
preventing periodontal disease was 
possible by instituting preventive dental 
health programs, and Randell et alz8 
suggested that prevention should be 
possible by providing better dental health 
services for children with Down 
syndrome. Sakellari et all9 described 
Age Categories Down Syndrome Group Healthy Children group Significance* 
Mean f SD Mean f SD 
AI-G (<5yr.) 










P<O.OOO 1 P<0.006 
AIII-G (>=10yr.) 2.595 0.43 _1  2.830 0.475 -I NS 
Fz10.806 p < 0.0001 F=3.388 p < 0.05 
*Differences between Down and control subjects were assessed by Mann-Whitney U test. 
Differences between age categories were assessed by ANOVA. 
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BANA Score 
Age Categories Down Syndrome Group Healthy children Group Significance* 
Mean f SD Mean f SD 
AI-G (<5yr.) 1.471 1.904 
AII-G ( 5  to 40yr . )  1.777 0.3881 < 2.052 
P<0.02 
1.81 1 0.276 _J 1.997 







*Differences between Down and control subjects were assessed by Mann-Whitney U test. 
Differences between age categories were assessed by ANOVA. 
the positive effects of closely monitoring 
the oral hygiene habits and frequent 
professional dental cleaning of five 
subjects with Down syndrome ages 26- 
37 years. Lopez et alzq reported that the 
overall characteristics of the periodontal 
and gingival health status in children 
with Down syndrome who received 
preventive care were not markedly 
different from those in healthy children. 
The results of our study agree with those 
reported by Lopez et al,29 in that we 
found no marked differences between 
the two groups in probing depth and 
plaque index. 
between the M-PMA index in children 
with Down syndrome and that of healthy 
children in three age categories. In the 
healthy children, the M-PMA index at 
the youngest age was significantly lower 
than that for age groups A11 or AIII. In 
the children with Down syndrome, 
however, no significant difference in the 
Our study focused on the difference 
M-PMA index was found in any of the 
age groups (A1 to AIII). Furthermore, 
when the groups were compared at each 
age category, M-PMA values for age 
groups A1 and AIII in the children with 
Down syndrome were significantly 
greater than those for the healthy 
children. Our results help to confirm the 
theories of early onset of periodontal 
disease in children with Down syndrome 
and also confirm that there is a greater 
severity of gingivitis in children with 
Down syndrome when compared to a 
control group of healthy children. 
Modeer et aI3" reported that alveolar 
bone loss, as a sign of periodontitis, was 
more frequently observed in children 
with Down syndrome ages 10 to 19 years 
than in healthy children, and that the 
symptoms tended to appear before age 
11. If we assume 4mm or more of 
probing depth to be periodontitis, our 
study does not support these 
conclusions. Barr-Agholme et al" and 
Nakagawa et a13L reported that the 
occurrence of periodontitis is related to 
their adolescence. The mean age of the 
subjects in the Modeer et a1 study3" was 
15.5 years, whereas the mean age of the 
subjects in our study was 7.6 years. In 
addition, our study did not find 4mm or 
more of probing depth in any of the 
subjects. In another study, subjects older 
than age 15 showed no significant 
increase in M-PMA index compared to 
subjects younger than age 15. 
Several reports have described 
the relationship between childhood 
periodontal disease and the flora in 
dental plaque. Nakagawa et al'l described 
the association of Porphyromonas 
gingivalis and Actinobacillus 
actinomycetemcomitans with adolescent 
gingivitis and adult periodontitis. 
Morinushi et all6 reported that these 
microorganisms were present in infancy 
and were associated with gingivitis. 
Abraham et a13+ acknowledged the 
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relationship between these two types of 
bacteria and periodontitis. A review by 
Robert et a135 described associations of 
destructive periodontitis in children 
affected with Actinobacillus 
actinomycetemcomitans, Prevotella 
intermedia and Spirochetes. Barr-Agholme 
et all6 reported higher levels of 
Actinobacillus. actinomycetemcomitans 
and Capnocytophaga in subgingival 
plaque in children with Down syndrome 
compared to the level in the healthy 
control group, while Santos et a137 
confirmed the existence of high level of 
A. actinomycetemcomitans in children 
with Down syndrome. Morinushi et allL 
examined the relationship between 
gingivitis in children with Down 
syndrome younger than age five and the 
microbiota associated with periodontal 
disease. They reported that adolescent 
gingivitis in their subjects was related to 
I1 gingivalis, A. actinomycetemcomitans, 
Selenomonas and Srep. mitis. Amano et 
all3 reported that B. forsythus, ?: denticola, 
E nigrescens and Campylobacter rectus 
were detected by polymerase chain 
reaction in all age groups of children 
with Down syndrome and that the 
frequency of detection of E gingivalis was 
significantly higher in these children 
after age five. These results suggest that 
E gingivalis and A. actinomycetemcomitans 
are involved in periodontal disease in 
children, and that the early onset of and 
tendency for gingival inflammation to be 
severe in children with Down syndrome 
are related to the early establishment of 
these periodontopathogens. 
The BANA test used in this study is a 
presumptive test for the periodontal 
pathogens T. denticola, E gingivalis and B. 
forsythus. Studies using “normal” subjects 
have demonstrated that Porphyromonas 
gingivalis, Treponema denticola and 
Bacteroides forsythus have been frequently 
associated with adult forms (periodontitis) 
of periodontal d i s e a ~ e . ‘ ~ ~ ’ ~ ~ ~ ~ ~ ’ ~ ~ ~ ~  
Furthermore, these BANA test-positive 
bacterial species may also be involved in 
periodontal disease seen in subjects with 
Down syndrome, and BANA test scores 
have been significantly associated with 
probing depths in adult subjects with 
Down syndrome.16 All subjects in the 
previous studies were older than age 16, 
and all had periodontitis. In our study, 
children with Down syndrome who had 
a mean age of 7.6 years, did not have a 
significant correlation between BANA 
test scores and other indices (M-PMA, 
PD). The mean BANA test score in each 
age category of both groups of children 
was low (under 2). Unfortunately, 
Actinobacillus actinomycetemcornitans, 
which is thought to be closely related to 
gingivitis, could not be found in our 
present study. 
In summary, this study showed that 
an early onset of gingivitis did occur in 
the children with Down syndrome and 
was more severe than in the healthy 
children. Probing depths in both groups 
increased with age. Despite the lower 
BANA test scores in all age groups of 
subjects with Down syndrome when 
compared with those of the healthy 
children, only the BANA test score for 
age group AIII was significantly higher 
than that of children for AI. The M-PMA 
index score at A111 in the children with 
Down syndrome was the highest of all the 
age categories. We speculate, therefore, 
that children with Down syndrome show 
a greater gingival inflammatory reaction 
to the periodontopathogens than healthy 
children, but that the progression of 
periodontal disease in subjects with 
Down syndrome can be controlled by 
routine preventive care, at least for those 
younger than age 15 years. 
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